EIA
MRK icon

Emerald Investment Advisers’s Merck MRK Stock Holding History

Emerald Investment Advisers’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.55M Buy
27,592
+788
+3% +$92.2K 0.24% 138
2026
Q1 		$3.22M Buy
+26,804
New +$3.09M 0.29% 115

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Emerald Investment Advisers's MRK Position: Q2 2026 in Review

Emerald Investment Advisers increased its Merck (MRK) stake by 2.9% in Q2 2026, buying an estimated $92.2K and bringing the position to 27,592 shares worth $3.55M. The position accounts for 0.24% of the portfolio, ranked #138.

Emerald Investment Advisers first reported a position in MRK in Q1 2026 and has held it in 2 quarters since. 3,817 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Emerald Investment Advisers held 27,592 shares of Merck worth $3.55M as of Q2 2026.
  • Emerald Investment Advisers bought 788 Merck shares in Q2 2026, an estimated $92.2K.
  • Merck made up 0.24% of Emerald Investment Advisers's portfolio in Q2 2026, its #138 holding.
  • Emerald Investment Advisers first reported a position in Merck in Q1 2026 and has held it in 2 quarters since.
  • 3,817 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Emerald Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.